Amgen Inc. buy UBS Group AG
Start price
06.01.26
/
50%
€283.85
Target price
06.01.27
-
Performance (%)
34.35%
Price
21.08.26
€376.30
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Amgen Inc. has seen massive gains of 34.35%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 4.834% | 4.834% |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat